Health supply, regulation and procurement news from across the United States, Canada and the Caribbean, curated by the Agentic Rx team.
FDA has approved Rextovy 4 mg naloxone nasal spray for over-the-counter sale, part of a wider push to move suitable medicines from prescription to OTC.
A new PAHO/WHO and OECS-PPS technical working group met in Saint Lucia to tackle stockouts, high prices and fragile supply chains, while Barbados moves to create a Medical…
New Health Canada amendments widen its shortage powers, allow lot-specific expiry extensions and add a 12-month non-sale notice for drugs. Device reporting changes follow in June 2027.
Articles summarise public news for general information only and are not medical, legal or regulatory advice. Each article links to its original sources.
